Fatih Selcukbiricik

7PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersMolecular targetsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Sub-acute care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 21, 2026
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.

|Sep 08, 2026
Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer.

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Apr 02, 2025
Late-onset recurrent immune checkpoint inhibitor-related pneumonitis after cessation of pembrolizumab: a case report.

Bahadır Köylü, Cevat İlteriş Kıkılı, Öner Dikensoy

|Jul 01, 2024
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.

Arif Akyildiz, Melis Gultekin, Ecem Yigit

|Aug 09, 2021
Palliative care needs of the cancer patients receiving active therapy.

Gülcan Bağçivan, Memnun Seven, Şeyma İnciser Paşalak

Pageof 2

Frequent Collaborators

4 joint publications

Bahadır Köylü

3 joint publications

Cevat İlteriş Kıkılı

2 joint publications

Nazan Demir

2 joint publications

Fatih Kemik